Clin2
NCT05958342Possibly a fitRecruiting

Calcium and vasopressin for bleeding shock after major injury

TraumaHemorrhage

Treatments studied

Part of Hormones & metabolism, Injuries & trauma, Kidney & urinary, Women’s health & pregnancy clinical trials.

This trial tests whether giving calcium and vasopressin early can improve outcomes in people with major injury who are at risk for life-threatening bleeding shock. It mainly includes patients who need rapid blood transfusion and likely major surgery to stop bleeding.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
1,050 people
Ages
18 years to 90 years
Study type
Interventional

Who can take part

  • You have had a serious injury and emergency team thinks you are at risk from dangerous bleeding
  • Your systolic blood pressure is very low (≤ 90) with fast heart rate (≥ 108) OR your systolic blood pressure is extremely low (≤ 70)
  • Blood transfusion has started in the field or within 60 minutes of arriving at the trauma center
  • The care team plans major surgery to control bleeding within 60 minutes of arriving (like opening the chest/abdomen or repairing major blood vessels)
  • You are expected to be admitted to the ICU
  • You can receive study treatment (the team must be able to place an IV or similar access line, and you must not have opted out)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06820645Not yet recruiting· Phase 2/Phase 3
Calcium treatment during severe bleeding emergencies

This trial tests whether giving calcium during massive blood transfusions helps trauma patients with severe bleeding. It may improve survival and recovery.

NCT05634109Recruiting· Phase 3
Whole blood to treat adults with severe bleeding trauma

This trial compares giving whole blood versus standard care in adults with severe trauma and dangerous blood loss (hemorrhagic shock). The goal is to see if whole blood helps stabilize patients faster and improves outcomes after major bleeding.

Cali, Valle del Cauca Department
NCT04387305Not yet recruiting· Phase 3
Tranexamic acid for bleeding after injury in children

This trial tests whether giving tranexamic acid (TXA), a medicine that helps blood clot, reduces death and disability in children who have bleeding after a severe injury. It is given within 3 hours of the injury, and could help children with head or torso trauma who are at risk of serious bleeding.

NCT07850427Not yet recruiting
Predicting early blood pressure problems in severely injured adults

This study is testing a new scoring system to predict which severely injured patients might develop dangerous drops in blood pressure shortly after arriving at the emergency room. By using simple checks like heart rate, blood tests, and an ultrasound, doctors hope to identify high-risk patients earlier so they can act faster.

NCT06495294Recruiting
Whole blood in trauma emergencies

This trial tests whether giving whole blood (instead of separate blood parts) to adults with major traumatic bleeding in the prehospital setting improves survival. It's for patients who need blood immediately after a serious injury.

Toronto, Ontario
NCT07869537Recruiting· Phase 4
Simplified tranexamic acid dosing for major bleeding after injury

This trial tests a simpler way to give a drug called tranexamic acid to trauma patients with heavy bleeding. The drug helps blood clot and may reduce bleeding, but it is important to check if the simplified approach is as safe as the standard one.

Hangzhou, Zhejiang

Hear when a new Trauma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.